Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine
Clinical trial NCT01928537 · COMPLETED
Trial details
- NCT number
- NCT01928537
- Sponsor
- Traws Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2017-06-29
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.